Indian Council of Medical Research former director-general Nirmal K. Ganguly on May 30 said that Monoclonal antibodies work as they're made against targeted epitope. He asserted that there are six receptor-binding domain points that are imp in spike protein, which undergo mutation/functional enhancement to create specific monoclonal antibody.